Market capitalization | €919.24m |
Enterprise Value | €996.21m |
PER (TTM) P/E ratio | 9.15 |
EV/FCF (TTM) EV/FCF | 5.88 |
EV/Sales (TTM) EV/Sales | 0.30 |
P/S ratio (TTM) P/S ratio | 0.27 |
P/B ratio (TTM) P/B ratio | 0.64 |
Dividend yield | 3.67% |
Last dividend (FY23) | €1.80 |
As a Free StocksGuide user, you can view scores for all 6,947 stocks worldwide.
5 Analysts have issued a Drägerwerk forecast:
5 Analysts have issued a Drägerwerk forecast:
Dec '23 |
+/-
%
|
||
Net Profit | 110 110 |
271%
271%
|
|
Depreciation and Amortization | 149 149 |
3%
3%
|
|
Stock Compensation | - - |
-
|
|
Operating Cash Flow | 190 190 |
232%
232%
|
|
Investments | 68 68 |
21%
21%
|
|
Dividend Paid | 3.68 3.68 |
0%
0%
|
|
Free Cash Flow | 125 125 |
156%
156%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Drägerwerk AG & Co. KGaA engages in the provision of medical and safety technology products. It operates through the following geographical segments: Europe; Americas; and Africa, Asia, and Austria (AAA). The company was founded by Johann Heinrich Draeger in 1889 and is headquartered in Luebeck, Germany.
Head office | Germany |
CEO | Stefan Dräger |
Employees | 16,329 |
Founded | 1889 |
Website | www.draeger.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.